Monsanto’s Business Model: Ethically Less Than the Sum of its Parts

Dandelion

From a great blog that covers ethical issues in the biotechnology industry.  Read the blog article here.

Excerpt:
Monsanto is widely considered to be Public Enemy #1 by critics of the biotech industry. But most who’ve heard complaints about Monsanto don’t know much more than what’s contained in the single-sentence slogans.

But if you’re going to form an opinion, it’s good to know a little more. As a start, here’s a good story by Christopher Leonard, writing for the Associated Press (and coming to you via The Atlanta Journal-Constitution), Monsanto seed biz role revealed. I strongly recommend the whole article. But here’s a taste:

“Confidential contracts detailing Monsanto Co.’s business practices reveal how the world’s biggest seed developer is squeezing competitors, controlling smaller seed companies and protecting its dominance over the multibillion-dollar market for genetically altered crops, an Associated Press investigation has found.

With Monsanto’s patented genes being inserted into roughly 95 percent of all soybeans and 80 percent of all corn grown in the U.S., the company also is using its wide reach to control the ability of new biotech firms to get wide distribution for their products, according to a review of several Monsanto licensing agreements and dozens of interviews with seed industry participants, agriculture and legal experts….”

Read more…

Leave a Reply

Your email address will not be published. Required fields are marked *